Aiomic Featured in BioWorld MedTech

Written By Torsten Jepsen

We're thrilled to announce that Aiomic has been featured in BioWorld MedTech for securing €1.3 million in funding from Denmark's Bioinnovation Institute (BII). The funding will enable us to further develop and commercialize our innovative AI platform, Aiomic360, designed to reduce postoperative complications.

Aiomic360 serves as a quality management tool for hospitals, a decision support tool for healthcare practitioners, and an individualized patient empowerment tool for surgical candidates. Its aim is to reduce the likelihood of complications like infections and readmissions, ultimately improving patient outcomes and reducing healthcare costs.

Read the full article here [https://lnkd.in/gREt25PV] and learn more about our efforts to address the hidden pandemic of postoperative complications.
 #Aiomic #BioWorldMedTech #AIinHealthcare #PostoperativeComplications

Torsten Jepsen
Previous

Aiomic to join accelerator program at the renowned Texas Medical Center
Next

Aiomic Secures 10 Million DKK in Funding to Reduce Postoperative Complications with AI-Powered Platform